| Subject: | Nationwide Recall of Two Lots of Sodium Polystyrene Sulfonate Suspension |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 16 Jul 2008 - 02:00 pm |
| The Food and Drug Administration and Roxane Laboratories, Inc. has announced a nationwide voluntary recall of two manufacturing lots of Sodium Polystyrene Sulfonate Suspension, USP, 15 g/60 mL Unit dose bottles (NDC 0054-0165-51; Lot 856396A Exp April 2010, and Lot 856693A Exp May 2010).A sample from product lot 856396A tested positive for a strain of yeast, which could potentially affect immunocompromised patients. There have been no complaints or adverse events reported for the affected... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|
